As Per the Report, the Size of the Europe Digital Breast Tomosynthesis (DBT) Equipment Market size is valued at USD 331.89 million in 2021 and is expected to grow at a CAGR of 13.5% to reach USD 625.13 million by 2026 during the forecast period 2021 to 2026. It captures 25% of the global market.
DBT is a 3D breast imaging technique. It operates on full field digital mammography technology. It has a rotating X-ray tube which projects multiple images from different angles at a low radiation dose through the compressed breast. A special monitor is utilized for image viewing.
Better alternative for 2D mammography resulting in higher adoption rate, savoury government policies, Upgradation of existing capital and purchases of new equipment, high risk of breast cancer, unhealthy lifestyle, rampant urbanization, and augmenting population are the primary drivers of market growth.
Europe Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented and sub-segmented into the following categories
On the basis of Hospitals captured larges market share. Its growth rate is projected to be nearly 15% for the forecast period.
On the basis of region, Europe is a close second in terms of market share. United Kingdom commanded the market in 2016. Growth for this market is predicted to slow down toward the tail end of the forecast period.
Prominent Companies dominating the Europe Digital Breast Tomosynthesis (Dbt) Equipment Market Profiled in the Report are Hologic Inc., Siemens Healthineers, Fujifilm Corporation. Other players in the market include GE Healthcare, Internazionale Medico Scientifica S.r.l. and Planmed Oy.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 DBT Equipment
5.1.3 3-D Upgradation
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals
5.2.3 Diagnostic Centres
5.2.4 Y-o-Y Growth Analysis, By End User
5.2.5 Market Attractiveness Analysis, By End User
5.2.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Siemens Healthineers
8.3 Fujifilm Corporation
8.4 GE Healthcare
8.5 Internazionale Medico Scientifica S.r.l.
8.6 Planmed OY
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
